Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
56.30
-0.50 (-0.88%)
Sep 10, 2025, 10:51 AM CST
-0.88%
Market Cap10.15B
Revenue (ttm)6.88B
Net Income (ttm)802.88M
Shares Out178.70M
EPS (ttm)4.49
PE Ratio12.65
Forward PEn/a
Dividend2.80 (4.93%)
Ex-Dividend DateAug 6, 2025
Volume101,601
Average Volume190,166
Open56.60
Previous Close56.80
Day's Range56.10 - 56.60
52-Week Range51.20 - 66.80
Beta0.04
RSI49.30
Earnings DateNov 6, 2025

About TPE:1720

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ... [Read more]

Sector Healthcare
Founded 1967
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 1720
Full Company Profile

Financial Performance

In 2024, TPE:1720's revenue was 6.79 billion, an increase of 8.81% compared to the previous year's 6.24 billion. Earnings were 880.50 million, an increase of 5.46%.

Financial Statements

News

There is no news available yet.